Literature DB >> 21142156

Ligand binding domain mutations of the glucocorticoid receptor selectively modify the effects with, but not binding of, cofactors.

Geun-Shik Lee1, S Stoney Simons.   

Abstract

We previously reported that several point mutations in the ligand binding domain (LBD) of glucocorticoid receptors (GRs) marginally affect the binding affinity of the synthetic glucocorticoids dexamethasone (Dex) and deacylcortivazol (DAC). However, these mutations dramatically alter the efficacy (A(max)) and potency (EC(50)) of agonists, along with the partial agonist activity (PAA) of the antisteroid Dex-mesylate (DM), for gene induction and repression in a steroid-dependent manner. This was proposed to result, in part, from altered protein-protein interactions in the complex of GR with the coactivator TIF2 despite normal TIF2 binding. To explore the generality of this phenomenon, we now ask whether these mutations also affect the transactivation properties, but not binding, of other GR-bound factors. We find that an elevated concentration of GR, to probe unidentified cofactors, or of the comodulator Ubc9 does not reverse the effects of GR LBD mutations that increase the EC(50) and lower the PAA with the GREtkLUC reporter in both CV-1 and U2OS cells. This behavior is more dramatic with Ubc9 and the isolated GR LBD fused to the GAL4 DNA binding domain, despite normal binding of Ubc9 to the mutant GRs. Similar effects, albeit gene, steroid, and transcriptional property-specific, are seen with full-length GRs and three endogenous genes in U2OS cells. Thus, changes in simple steady-state binding capacities of mutant receptors for factors cannot account for the modified transcriptional properties. In all cases, the nuclear translocation of Dex- and DAC-bound wild-type and mutant receptors is the same. These results are consistent with the earlier results with TIF2 and support the hypothesis that small changes in the GR LBD can alter the activities of the bound cofactor without modifying cofactor binding. We propose that this separation of binding and the modulation of transactivation parameters occurs for a wide variety of GR-associated cofactors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142156      PMCID: PMC3123670          DOI: 10.1021/bi101792d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

Review 1.  Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions.

Authors:  Raj Kumar; E Brad Thompson
Journal:  Mol Endocrinol       Date:  2003-01

2.  Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors.

Authors:  Sunil Kaul; John A Blackford; Sehyung Cho; S Stoney Simons
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

3.  Anti-inflammatory pyrazolo-steroids: potent glucocorticoids containing bulky A-ring substituents and no C3-carbonyl.

Authors:  S S Simons; E B Thompson; D F Johnson
Journal:  Biochem Biophys Res Commun       Date:  1979-02-14       Impact factor: 3.575

4.  Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription.

Authors:  S Chen; N J Sarlis; S S Simons
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

5.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

Authors:  H Poukka; U Karvonen; O A Janne; J J Palvimo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

6.  Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration.

Authors:  D Szapary; M Xu; S S Simons
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

Review 7.  The importance of being varied in steroid receptor transactivation.

Authors:  S Stoney Simons
Journal:  Trends Pharmacol Sci       Date:  2003-05       Impact factor: 14.819

8.  Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.

Authors:  Qi Wang; John A Blackford; Liang-Nian Song; Ying Huang; Sehyung Cho; S Stoney Simons
Journal:  Mol Endocrinol       Date:  2004-03-11

9.  Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor.

Authors:  Inez Rogatsky; Jen-Chywan Wang; Mika K Derynck; Daisuke F Nonaka; Daniel B Khodabakhsh; Christopher M Haqq; Beatrice D Darimont; Michael J Garabedian; Keith R Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

10.  Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.

Authors:  Randy K Bledsoe; Valerie G Montana; Thomas B Stanley; Chris J Delves; Christopher J Apolito; David D McKee; Thomas G Consler; Derek J Parks; Eugene L Stewart; Timothy M Willson; Millard H Lambert; John T Moore; Kenneth H Pearce; H Eric Xu
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

View more
  12 in total

Review 1.  Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges.

Authors:  S Stoney Simons; Dean P Edwards; Raj Kumar
Journal:  Mol Endocrinol       Date:  2013-11-27

2.  Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.

Authors:  Shagufta H Khan; Smita Awasthi; Chunhua Guo; Devrishi Goswami; Jun Ling; Patrick R Griffin; S Stoney Simons; Raj Kumar
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

3.  Identification of location and kinetically defined mechanism of cofactors and reporter genes in the cascade of steroid-regulated transactivation.

Authors:  John A Blackford; Chunhua Guo; Rong Zhu; Edward J Dougherty; Carson C Chow; S Stoney Simons
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

4.  Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.

Authors:  Smita Awasthi; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2012-02-11       Impact factor: 4.102

Review 5.  The road less traveled: new views of steroid receptor action from the path of dose-response curves.

Authors:  S Stoney Simons; Carson C Chow
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

6.  PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation.

Authors:  Zhenhuan Zhang; Yunguang Sun; Young-Wook Cho; Carson C Chow; S Stoney Simons
Journal:  J Biol Chem       Date:  2012-11-17       Impact factor: 5.157

7.  A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties.

Authors:  Min Luo; Xinping Lu; Rong Zhu; Zhenhuan Zhang; Carson C Chow; Rong Li; S Stoney Simons
Journal:  J Biol Chem       Date:  2013-10-06       Impact factor: 5.157

8.  RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.

Authors:  Jimena Druker; Ana C Liberman; María Antunica-Noguerol; Juan Gerez; Marcelo Paez-Pereda; Theo Rein; Jorge A Iñiguez-Lluhí; Florian Holsboer; Eduardo Arzt
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

9.  Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction.

Authors:  Madhumita A Pradhan; John A Blackford; Ballachanda N Devaiah; Petria S Thompson; Carson C Chow; Dinah S Singer; S Stoney Simons
Journal:  J Biol Chem       Date:  2015-10-26       Impact factor: 5.157

10.  Theory of partial agonist activity of steroid hormones.

Authors:  Carson C Chow; Karen M Ong; Benjamin Kagan; S Stoney Simons
Journal:  AIMS Mol Sci       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.